Non-invasive skin cancer treatment manufactured by ANSTO in Southern Sydney
ANSTO has been licensed as the Australian manufacturing partner of an innovative, non-invasive treatment for non-melanoma skin cancer (NMSC).
Showing 1161 - 1180 of 2688 results
ANSTO has been licensed as the Australian manufacturing partner of an innovative, non-invasive treatment for non-melanoma skin cancer (NMSC).
The first experimental evidence to validate a newly published universal law that provides insights into the complex energy states for liquids has been found using an advanced nuclear technique at ANSTO.
Nine PhD students are taking part in a rare opportunity to deliver an innovative solution to a real-world challenge for an industry partner in ANSTO’s National Graduate Innovation Forum in association with the Australian Council of Deans of Science and the Australian Institute of Nuclear Science and Engineering.
The Australian Synchrotron has an on-site Guesthouse for users and AS guests.
Come and discover the world of science at the Australian Synchrotron - book a school tour today.
Guide to successful proposals and experiments at the Powder Diffraction beamline.
Book a date with the Discovery Centre for your class.
Thirty years of ANSTO's unique capability in monitoring fine particle pollution provides insight on bushfire smoke.
Highlighting the contribution of four inspirational ANSTO leaders on International Women's Day.
Understanding of the role that programmed cell death has in development.
ANSTO providing support to emergency services, closed to non-essential staff.
ANSTO is contributing to key critical minerals projects funded by the Federal Government.
ANSTO is a registered Research Service Provider (RSP), registration number 12657, under section 29A of the Industry Research and Development Act 1986.
This state-of-the-art metastable-exchange optical-pumping helium-3 polarising system enables polarisation-analysis experiments on five of our existing instruments.